ETR:FME - Fresenius Medical Care AG & Co. KGaA Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started €68.50 +1.04 (+1.54 %) (As of 02/15/2019 04:00 PM ET)Previous Close€68.50Today's Range€67.24 - €69.4852-Week Range€75.53 - €93.82Volume1.11 million shsAverage Volume704,197 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist and intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; and offers non-dialysis products, including acute cardiopulmonary and apheresis products. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2017, it operated 3,752 outpatient dialysis clinics in approximately 50 countries. The company has operations in Germany, the United States, and internationally. Fresenius Medical Care AG & Co. KGaA was founded in 1996 and is headquartered in Bad Homburg, Germany. Receive FME News and Ratings via Email Sign-up to receive the latest news and ratings for FME and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange ETR Industry Medical Care Sub-IndustryN/A SectorMedical Current SymbolETR:FME Previous Symbol CUSIPN/A Webwww.freseniusmedicalcare.com Phone+49-6172-6090Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees112,134 Outstanding SharesN/AMarket CapN/A OptionableNot Optionable Fresenius Medical Care AG & Co. KGaA (ETR:FME) Frequently Asked Questions What is Fresenius Medical Care AG & Co. KGaA's stock symbol? Fresenius Medical Care AG & Co. KGaA trades on the ETR under the ticker symbol "FME." What price target have analysts set for FME? 20 brokers have issued 1 year price targets for Fresenius Medical Care AG & Co. KGaA's shares. Their predictions range from €66.00 to €102.00. On average, they anticipate Fresenius Medical Care AG & Co. KGaA's share price to reach €82.75 in the next twelve months. This suggests a possible upside of 20.8% from the stock's current price. View Analyst Price Targets for Fresenius Medical Care AG & Co. KGaA. What is the consensus analysts' recommendation for Fresenius Medical Care AG & Co. KGaA? 20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last year. There are currently 9 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Fresenius Medical Care AG & Co. KGaA. Has Fresenius Medical Care AG & Co. KGaA been receiving favorable news coverage? News coverage about FME stock has trended neutral on Saturday, according to InfoTrie. The research group identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Fresenius Medical Care AG & Co. KGaA earned a media sentiment score of 0.2 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. Who are some of Fresenius Medical Care AG & Co. KGaA's key competitors? Some companies that are related to Fresenius Medical Care AG & Co. KGaA include Amadeus It Group (AMS), Blvd Centers (CXV), Cambian Group (CMBN), CareTech (CTH), CHAMPION PAIN C/SH SH (CPAI), Eviana Health (EHC), Georgia Healthcare Group (GHG), Medical Facilities (MFCSF), Mediclinic International (MDC), Premier Health Group (PHGI), Ramsay Health Care Limited Fully Paid Ord. Shrs (RMSYF), Rhoen Klinikum (RHK), RHOEN-KLINIKUM/ADR (RKAGY), SONIC HEALTHCAR/S (SKHHY) and Sonic Healthcare (SKHCF). Who are Fresenius Medical Care AG & Co. KGaA's key executives? Fresenius Medical Care AG & Co. KGaA's management team includes the folowing people: Mr. Robert Maurice Powell Jr., Chairman of the Mgmt Board & CEO of Fresenius Medical Care Mgmt AG (Age 64)Mr. Michael Brosnan, CFO & Member of the Mgmt Board at Fresenius Medical Care Mgmt AG (Age 64)Mr. Kent Wanzek, CEO of Global Mfg & Quality & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 60)Dr. Olaf Schermeier, CEO of Global R&D and Member of the Mgmt Board - Fresenius Medical Care Mgmt AG (Age 47)Mr. Harry de Wit, CEO of APAC & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 57) What is Fresenius Medical Care AG & Co. KGaA's stock price today? One share of FME stock can currently be purchased for approximately €68.50. What is Fresenius Medical Care AG & Co. KGaA's official website? The official website for Fresenius Medical Care AG & Co. KGaA is http://www.freseniusmedicalcare.com/. How can I contact Fresenius Medical Care AG & Co. KGaA? Fresenius Medical Care AG & Co. KGaA's mailing address is Else-Kroener-Strasse 1, BAD HOMBURG, 61352, Germany. The company can be reached via phone at +49-6172-6090. MarketBeat Community Rating for Fresenius Medical Care AG & Co. KGaA (ETR FME)Community Ranking: 3.0 out of 5 ( )Outperform Votes: 835 (Vote Outperform)Underperform Votes: 538 (Vote Underperform)Total Votes: 1,373MarketBeat's community ratings are surveys of what our community members think about Fresenius Medical Care AG & Co. KGaA and other stocks. Vote "Outperform" if you believe FME will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FME will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/16/2019 by MarketBeat.com StaffFeatured Article: What is Considered a Good Return on Equity (ROE)?